To the full analysis
Buyback calculator for Charles River Laboratories International
Charles River Laboratories International stock: key metrics
CRLCharles River Laboratories International had an operating margin of 12.6% and a return on invested capital (ROIC) of 6.6% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2006 | 38.4% | 17.8% | −5.3% |
| 2007 | 38.9% | 18.5% | 12.5% |
| 2008 | 38.0% | −33.5% | −38.8% |
| 2009 | 35.2% | 14.1% | 9.5% |
| 2010 | 33.9% | −26.3% | −29.7% |
| 2011 | 35.2% | 15.3% | 9.6% |
| 2012 | 34.7% | 14.7% | 8.6% |
| 2013 | 33.9% | 13.0% | 8.8% |
| 2014 | 36.4% | 13.7% | 9.8% |
| 2015 | 39.0% | 15.1% | 11.0% |
| 2016 | 38.3% | 14.1% | 9.2% |
| 2017 | 37.7% | 15.5% | 6.6% |
| 2018 | 37.1% | 14.6% | 10.0% |
| 2019 | 36.6% | 13.4% | 9.6% |
| 2020 | 36.7% | 14.8% | 12.5% |
| 2021 | 37.7% | 16.7% | 11.0% |
| 2022 | 36.8% | 16.4% | 12.2% |
| 2023 | 36.4% | 14.9% | 11.5% |
| 2024 | 32.9% | 5.6% | 0.3% |
| 2025 | 30.5% | 12.6% | −3.6% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2006 | −3.5% | 6.8% | −2.2% |
| 2007 | 8.3% | 8.0% | 5.5% |
| 2008 | −43.5% | −19.4% | −24.2% |
| 2009 | 8.3% | 7.7% | 5.2% |
| 2010 | −49.0% | −16.4% | −19.4% |
| 2011 | 20.8% | 12.8% | 7.0% |
| 2012 | 16.2% | 11.2% | 6.1% |
| 2013 | 16.0% | 9.9% | 6.3% |
| 2014 | 18.8% | 10.4% | 6.7% |
| 2015 | 20.4% | 11.3% | 7.2% |
| 2016 | 18.5% | 9.6% | 5.7% |
| 2017 | 11.8% | 7.2% | 4.2% |
| 2018 | 17.2% | 10.9% | 5.9% |
| 2019 | 15.4% | 9.3% | 5.4% |
| 2020 | 17.2% | 9.4% | 6.6% |
| 2021 | 15.4% | 10.2% | 5.6% |
| 2022 | 16.3% | 9.0% | 6.4% |
| 2023 | 13.2% | 8.3% | 5.8% |
| 2024 | 0.3% | 1.8% | 0.1% |
| 2025 | −4.6% | 6.6% | −2.0% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 27 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 7 Aug 2026)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.